Seres Therapeutics, Inc. - COMMON STOCK (MCRB)

Q2 2025 13F Holders as of 6/30/2025

Type / Class
Equity / COMMON STOCK
Shares outstanding
170M
Number of holders
0
Total 13F shares, excl. options
0
Shares change
-61.4M
Total reported value, excl. options
$0
Value change
-$42.9M
Number of sells
-57

Significant Holders of Seres Therapeutics, Inc. - COMMON STOCK (MCRB) as of Q2 2025

62 filings reported holding MCRB - Seres Therapeutics, Inc. - COMMON STOCK as of Q2 2025.
Seres Therapeutics, Inc. - COMMON STOCK (MCRB) has 0 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC). These institutions hold a total of 0 shares of 170M outstanding shares and own 0% of the company stock.
Largest 10 shareholders include Farther Finance Advisors, LLC (0 shares), Janney Montgomery Scott LLC (0 shares), Sound Income Strategies, LLC (0 shares), Vontobel Holding Ltd. (0 shares), Vanguard Personalized Indexing Management, LLC (0 shares), Aries Wealth Management (0 shares), TFC Financial Management, Inc. (0 shares), WHITTIER TRUST CO (0 shares), NISA INVESTMENT ADVISORS, LLC (0 shares), and Diversified Trust Co (0 shares).
This table shows the top 0 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
Investor Option Weight % Change % Value $ * Price $ Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.